Parathyroid cancer is a very rare type of cancer that starts in the parathyroid gland. It can cause hyperparathyroidism, which can result in high calcium levels in the blood. The most common treatment ...

Fred Hutchinson Cancer Center treats the full range of cancers that can affect endocrine glands, including your parathyroid glands. Our endocrine tumor experts are UW Medicine physicians who also see ...

September 19, 2007--Cinacalcet ( Sensipar, Amgen) may emerge as an important new therapeutic option for patients with inoperable parathyroid carcinoma, researchers report. According to the results of ...

A newly-created prognostic tool reliably predicts the recurrence of parathyroid cancer, enabling physicians to identify patients at the highest risk. Consequently, the tool also helps to determine the ...

Parathyroid carcinoma (PC) is a rare entity with profound oncologic and surgical implications, accounting for < 1% of cases of primary hyperparathyroidism (PHPT). PC typically presents as severe PHPT, ...

At Fred Hutchinson Cancer Center, we surround you with experts who focus completely on cancer, day in and day out. A handful of people form the core of your care team. You have an oncologist who ...

New research reveals that the drug cinacalcet HCl (cinacalcet) may effectively reduce the dangerous accumulation of calcium in the blood that typically accompanies parathyroid cancer. This drug ...

This Journal feature begins with a case vignette highlighting a common clinical problem. Evidence supporting various strategies is then presented, followed by a review of formal guidelines, when they ...

Multiple Endocrine Neoplasia Type 1 is a rare genetic disorder associated with a high risk of developing tumors in your parathyroid gland and pituitary gland, and your pancreas. Multiple endocrine ...

Background A 54-year-old man presented to the emergency department of his local hospital with a 1-year history of fatigue, weight loss, and constipation. He had abused alcohol for many years, and his ...

Phase I dose escalation study of pan-histone deacetylase (HDAC) inhibitor abexinostat in combination with cisplatin in patients with advanced non-keratinizing nasopharyngeal carcinoma. E1308: ...

Prostate cancer (PCa)bone metastases are unique in that majority of them induce excessive mineralized bone matrix, through undefined mechanisms, as opposed to most other cancers that induce bone ...